Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2024 08:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics’ Portfolio Elevated by Updated NCCN Prostate Cancer Guidelines

Myriad Genetics’ full suite of urologic oncology products is elevated by updated NCCN prostate cancer guidelines.